Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/624,003external-prioritypatent/US6312708B1/en
Application filed by Allergan Sales IncfiledCriticalAllergan Sales Inc
Publication of AR028670A1publicationCriticalpatent/AR028670A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un sistema de liberacion controlada para la liberacion in vivo multifásica de cantidades terapéuticas de toxina botulínica en un paciente humano durante un período prolongado. El sistema de liberacion controlada puede comprender una pluralidad de microesferas poliméricas que incorporan toxina botulínica.A controlled release system for the in vivo multiphasic release of therapeutic amounts of botulinum toxin in a human patient for a prolonged period. The controlled release system may comprise a plurality of polymer microspheres that incorporate botulinum toxin.